Abstract: Novel polypeptide compositions based on the amino acid sequence of tissue plasminogen activator (tPA) are provided having improved properties over natural tissue plasminogen activator. Particularly, reduced fibrin stimulation of plasminogenolytic activity and/or enhanced affinity to fibrin surfaces are provided by modifying the C-terminus by deletions.
Type:
Grant
Filed:
January 31, 1995
Date of Patent:
August 12, 1997
Assignees:
Chiron Corp., Behringwerke AG
Inventors:
Nancy L. Haigwood, Guy Mullenbach, Ernst-Guenter Afting, Eric Paul Paques